[3P-629] Neovasculature-targeted lipoprotein mutant eye drops for the treatment of wet age-related macular degeneration in mice

^○Ryo Kawakami¹, Ryosuke Fukada¹, Kenji Suda², Eri Nakano², Ai Ichioka², Akitaka Tsujikawa², Tatsuya Murakami^1,3 (1.Dept. of Biol. Pharm., Grad. Sch. of Eng., Toyama Pref. Univ., 2.Dept. of Ophthalmol. Vis. Sci., Grad. Sch. of Med., Kyoto Univ., 3.Inst. for Integr. Cell-Mater. Sci.(iCeMS), Kyoto Univ. Inst. for Adv. Stud.(KUIAS))